Carfilzomib 56mg/m2 Twice-Weekly in Combination with Dexamethasone and Daratumumab (KdD) Versus Daratumumab in Combination with 8 Cycles of Bortezomib and Dexamethasone (DVd); A Matching-Adjusted Indirect Treatment Comparison
Year: 2020
Type: article
Source: Blood
Institutions: University Medical Center Hamburg-Eppendorf, Emory University, Winship Cancer Institute, National and Kapodistrian University of Athens, The Alfred Hospital, Monash University, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Amgen (Switzerland), Amgen (United Kingdom), Amgen (United States), Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096698499